Showing results (451-460 of 645) with videos related to
Sort By:
Pageof 65
Thrombosis and Haemostasis|December 18, 1987
Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancyV Ballegeer, P Mombaerts, P J Declerck, et al.Clinical & Experimental Metastasis|August 5, 2000
ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferationM Seddighzadeh, J N Zhou, U Kronenwett, et al.Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesisA Agren, B Wiman, V Stiller, et al.Blood|January 1, 1988
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assayP J Declerck, M C Alessi, M Verstreken, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic miceP Holvoet, B De Geest, S Van Linthout, et al.The American Journal of Pathology|June 15, 2000
Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarctionE Creemers, J Cleutjens, J Smits, et al.Circulation|July 1, 1985
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbitsG Agnelli, M R Buchanan, F Fernandez, et al.Biochimica Et Biophysica Acta|October 6, 1993
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1)D E Vaughan, P J Declerck, T M Reilly, et al.Circulation|August 1, 1985
Coronary thrombolysis in dogs with intravenously administered human pro-urokinaseD Collen, D Stump, F van de Werf, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient miceT VandenDriessche, V Vanslembrouck, I Goovaerts, et al.Pageof 65